Oncotarget

Retraction:

Retraction: MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2

PDF |  Full Text  |  How to cite

Oncotarget. 2022; 13:863-863. https://doi.org/10.18632/oncotarget.28253

Metrics: PDF 642 views  |   Full Text 363 views  |   ?  

Na Li, Lufei Wang, Guangyun Tan, Zhiheng Guo, Lei Liu, Ming Yang _ and Jin He _

Abstract

Na Li1, Lufei Wang2, Guangyun Tan3, Zhiheng Guo1, Lei Liu1, Ming Yang4,* and Jin He1,*

1 Department of Gynecology and Obstetrics, The First Hospital of Jilin University, Changchun, Jilin 130021, PR China

2 Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130022, PR China

3 Department of Immunology, Institute of Translational Medicine of The First Hospital of Jilin University, Changchun, Jilin 130021, PR China

4 Department of Breast Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, PR China

* These authors have contributed equally to this work

Correspondence to:

Ming Yang, email: [email protected]
Jin He, email: [email protected]

Keywords:

Received: RECEIVED_DATE     Accepted: ACCEPTED_DATE     Published: July 02, 2022

Copyright: © 2022 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget has completed its investigation of this paper. We found that Figures 2C, 2E, 5C, 5D, 6E, and Table 1 contain similarities with data appearing in other articles by different authors. The data had already been published elsewhere, or were already under consideration for publication prior to submission to Oncotarget. During our long period of communication with the authors, we received a request from corresponding author Jin He to retract the paper. As of this writing, Oncotarget has not received signed documentation from all authors acknowledging the retraction. Oncotarget has also notified the affiliated institution regarding this retraction.

Original article: Oncotarget. 2017; 8:91530–91541. 91530-91541. https://doi.org/10.18632/oncotarget.21069


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28253